OneDigital Investment Advisors’s Intellia Therapeutics NTLA Stock Holding History

OneDigital Investment Advisors’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,950	Closed	-$231K	–	818
2021 Q4	$231K	Sell	1,950 -983	-34%	-$123K	0.01%	681
2021 Q3	$393K	Buy	2,933 +265	+10%	+$40.1K	0.02%	492
2021 Q2	$432K	Sell	2,668 -3,390	-56%	-$264K	0.02%	450
2021 Q1	$486K	Sell	6,058 -53	-0.9%	-$3.56K	0.02%	389
2020 Q4	$332K	Buy	+6,111	New	+$222K	0.02%	463
2020 Q1	–	Sell	-10,700	Closed	-$157K	–	611
2019 Q4	$157K	Buy	+10,700	New	+$149K	0.01%	536
2019 Q3	–	Sell	-8,648	Closed	-$142K	–	955
2019 Q2	$142K	Buy	8,648 +3,250	+60%	+$51.1K	0.01%	429
2019 Q1	$92K	Buy	+5,398	New	+$80.5K	0.01%	387

Other funds holding NTLA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

OneDigital Investment Advisors's NTLA Position: Q1 2022 in Review

OneDigital Investment Advisors sold out of Intellia Therapeutics (NTLA) in Q1 2022, closing a stake of 1,950 shares — an estimated $231K sold.

OneDigital Investment Advisors first reported a position in NTLA in Q1 2019 and held it in 8 quarters. The position peaked at $486K in Q1 2021. 349 funds tracked by Wall St. Rank hold NTLA as of Q1 2022.

OneDigital Investment Advisors reported no remaining Intellia Therapeutics position as of Q1 2022 after selling out during the quarter.
OneDigital Investment Advisors sold 1,950 Intellia Therapeutics shares in Q1 2022, an estimated $231K.
OneDigital Investment Advisors first reported a position in Intellia Therapeutics in Q1 2019 and held it in 8 quarters.
OneDigital Investment Advisors's Intellia Therapeutics position peaked at $486K in Q1 2021.
349 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2022.

Based on OneDigital Investment Advisors's 13F filing for Q1 2022, filed 5 May 2022.